Collaboration is an essential part of DNDi’s virtual R&D model: we cannot carry out our work without the engagement of public and private partners.
Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners and service providers in more than 40 countries.
Industry partners and service providers
Loading…
Accelera
Italy

Ajinomoto Bio-Pharma Services (GeneDesign, Inc.)
Japan
Loading…

Amatsi Aquitaine (formerly Bertin Pharma)
France
Loading…

AMG Consultants
UK
Loading…

Anacor Pharmaceuticals (now Pfizer Inc.)
USA
Loading…

Aptuit
Italy

Astellas Pharma Inc.
Japan

AstraZeneca
Sweden

AstraZeneca UK
United Kingdom
Loading…

BaseCon A/S
Denmark
Loading…

Basilea Pharmaceutica AG
Switzerland
Loading…

Bayer AG
Germany

BioDelivery Sciences International Inc.
USA
Loading…
Loading…

Boehringer Ingelheim
Germany
Loading…

Brazilian Biosciences National Laboratory (LNBio)
Brazil
Loading…

Celgene – Bristol-Myers Squibb Company
USA

Charles River Laboratories (formerly WIL Research)
France

Daiichi Sankyo
Japan

Daiichi Sankyo RD Novare Co., Ltd.,
Japan
Loading…

Dow AgroSciences LLC
USA
Loading…

Eisai Co., Ltd.
Japan

Epichem
Australia
Loading…

Eurofarma
Brazil
Loading…

Eurofins CEREP
France
Loading…

Eurofins Panlabs
USA
Loading…

Genomics Institute of The Novartis Research Foundation (GNF)
USA
Loading…
Loading…

GlaxoSmithKline (GSK)
UK
Loading…

GlaxoSmithKline (GSK) – Spain